NCT02962934View on ClinicalTrials.gov

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

August 31, 2019

Conditions
Gram-Negative Bacterial Infections
Interventions
OTHER

Non CRRT group

Non CRRT group:Blood samples prior to first dose of Ceftolozane-Tazobactam and at 15, 45, 1hr, 2hr 3hr 4h 5h 6h 7h 8h.

OTHER

CRRT group

"CRRT group: Pre and Post dialysis filter blood samples taken prior to first dose of Ceftolozane-tazobactam and at 15min, 45min, 1h 2h 3h 4h 5h 6h 7h 8h.~Ultrafiltrate samples at 1 hr,2h 4h 6h 8h"

Trial Locations (1)

4029

Royal Brisbane and Women's Hospital, Brisbane

All Listed Sponsors
collaborator

The University of Queensland

OTHER

lead

Royal Brisbane and Women's Hospital

OTHER_GOV

NCT02962934 - An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT | Biotech Hunter | Biotech Hunter